INTERVENTIONS FOR VALVULAR DISEASE AND HEART FAILURE

Combination of high-sensitivity C-reactive protein with logistic EuroSCORE improves risk stratification in patients undergoing TAVI

EuroIntervention 2018;14:629-636 published online June 2018. DOI: 10.4244/EIJ-D-18-00059

Anja Stundl1, MD; Laura Busse1, MD; Philipp Leimkühler1, MD; Marcel Weber1, MD; Berndt Zur2, MD; Fritz Mellert3, MD; Eberhard Grube1, MD; Georg Nickenig1, MD; Nikos Werner1, MD; Jan-Malte Sinning1, MD

1. Department of Medicine II, Heart Center Bonn, University Hospital Bonn, Bonn, Germany; 2. Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn, Germany; 3. Department of Cardiothoracic Surgery, Heart Center Bonn, Un

Aims: The aim of this study was to assess the clinical value of biomarkers to identify TAVI patients at high risk for adverse outcome, to assess whether these biomarkers provide prognosti

Forgot your password?

No account yet? Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

aortic stenosisrisk stratificationtavi

Interventions for valvular diseaseTAVI

Share on Facebook Share on Twitter Share on Linkedin